Table 1.
Comparison of G2/M phase induction by α-santalol in A431 cells and UACC-62 cells
| Time of treatment | Conc. of α-santalol (μM) | Percentage of G2/M phase induction by α-santalol as compared to control * | |
|---|---|---|---|
| p53 mutated human epidermoid carcinoma A431 cells | p53 wild-type human melanoma UACC-62 cells | ||
| 6 h | 50 | 49.1 | 70.9 |
| 75 | 48.8 | 65.2 | |
| 12 h | 50 | 171.1 | 148.7 |
| 75 | 235.5 | 149 | |
| 24 h | 50 | 27.2 | 226 |
| 75 | 285 | 305.5 | |
*: Data were expressed as the percentage of the induction of α-santalol treated groups in G2/M phase to untreated controls.